Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03147001
Other study ID # 50968
Secondary ID
Status Completed
Phase N/A
First received May 8, 2017
Last updated May 8, 2017
Start date April 30, 2016
Est. completion date January 10, 2017

Study information

Verified date May 2017
Source University of Aarhus
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

A randomized interventions study using a crossover design. Ten well trained triathletes or bikeriders will be included for to undergo two trail separated by about 3 weeks. The night before the trail each subject will performe a high intense interval trainings session on an ergometer bike. during the night an infusion of aminoacid tracers will be initiated. The subject is woken at 6.30 a.m. Blood samples and a musclebiopsy will be collected prior to the morning bike ride at 8.00a.m. Immediately before the morning bike ride is started the subject will ingest a drink of 0,5g protein or a non-caloric placebo (random order). During the bike ride and the following 4,5 hours blood will be drawn with regular intervals. at time point 0, 60 and 180 min after the training session biopsies are collected.


Recruitment information / eligibility

Status Completed
Enrollment 9
Est. completion date January 10, 2017
Est. primary completion date January 10, 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria:

- Healthy well-trained triathletes or cyclists

- VO2max > 55 ml O2/kg/min

- Training and has been training more than 7 times a week the last 6 months.

Exclusion Criteria:

- VO2max < 55 ml O2/kg/min

- Has chronic disease

- has incjected with tracer on a previous occasion.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Protein ingestion
A protein drink was ingested prior to the 90min bike ride in one of the completed trails (order randomised).
Non-caloric placebo ingestion
A placebo drink was ingested prior to the 90min bike ride in one of the completed trails (order randomised).

Locations

Country Name City State
n/a

Sponsors (4)

Lead Sponsor Collaborator
University of Aarhus Arla Foods, Innovation Fund Denmark, Team Denmark

Outcome

Type Measure Description Time frame Safety issue
Primary Muscle protein fractional synthetic rate (FSR) FSR was measure over at time period of six hours
Secondary Tracer kinetics dilution model A-V tracer dilution model was applied across the forearm. six hours
Secondary Muscle signalling Muscle signalling will be determined using western blotting in each muscle biopsy Determined in biopsies sampled before and immediatly after 90min exercise in addition to one and four hours after exercise.
Secondary Nitrogen excretion nitrogen excretion is determined by Plasma and urinary carbide analysis as well as plasma NH4+. Urine is collected during two periods. Collection period one: 12 hours prior to morning exercise. Collection period 2: During and four hours following exercise. Blood samples is drawn repeatedly from before to four hours after exercise.
See also
  Status Clinical Trial Phase
Completed NCT01143493 - The Role of Glucocorticoid Receptor SNPs in Receptor Function and Metabolic Disease
Active, not recruiting NCT01461603 - Local Effects of Amino Acids and 3-hydroxybutyrate in the Bilaterally Perfused Human Leg N/A
Completed NCT04422665 - Preventing Bed-rest Induced Muscle Loss in the Elderly N/A
Completed NCT04121689 - Time Course of Postprandial Protein Metabolism N/A
Completed NCT01820702 - Short Term Bed Rest Study: Evaluation of the Use of Artificial Gravity, Induced by Short-arm Centrifugation N/A
Completed NCT03142737 - Are the "Ounce-equivalents" in the Protein Foods Groups Really Equivalent? N/A
Completed NCT03952884 - Skeletal Muscle Protein Synthetic Response to Amino Acid and Peptides N/A
Completed NCT05197140 - Role of the Protein Matrix in the Anabolic Response to a Ground Beef Patty as Opposed to the Impossible (Vegi-) Burger N/A
Completed NCT04821557 - Effect of Microbial Protease Supplementation on Postprandial Amino Acid Levels N/A
Recruiting NCT05400733 - Prandial Metabolic Phenotype in Adults N/A
Terminated NCT00586807 - Metabolic Response to Infliximab in Pediatric Ulcerative Colitis N/A
Completed NCT01276795 - Whey Protein-based Enteral Nutrition Support to Improve Protein Economy in Surgical Patients N/A
Completed NCT00586352 - Protein Metabolism in Newly Diagnosed Pediatric Inflammatory Bowel Disease N/A
Completed NCT03037294 - Protein Turnover in the Osteoarthritic Knee N/A
Completed NCT01509456 - The Effect of Potassium Bicarbonate on Bone and Several Physiological Systems During Immobilisation N/A
Completed NCT00583232 - Protein and Energy Metabolism in Pediatric Crohn's Disease Phase 1
Completed NCT03179462 - "Ounce-equivalents" in the Protein Foods Group: Benefits of Quality N/A
Completed NCT03326284 - Optimal Protein Dose Per Meal During Weight Loss in Perspective to Maintaining Muscle Mass N/A
Active, not recruiting NCT00497380 - Arginine Feeding: a Novel Strategy to Improve Protein Metabolism in Cancer and the Response to Surgery N/A